Centro De Quimioterapia Oncoclinicas Sa Clinic in Brazil

Oncoclínicas&Co is a healthcare organization founded in 2010 by oncologist Bruno Ferrari in Belo Horizonte, Brazil. The clinic specializes in oncology, hematology, radiotherapy, and genomics, providing a comprehensive range of cancer-related services for both adult and pediatric patients. Its network includes clinics, hospitals, and laboratories located across several Brazilian states, such as Minas Gerais, Rio de Janeiro, and São Paulo.

The organization delivers a broad spectrum of diagnostic and treatment services, including chemotherapy, immunotherapy, radiotherapy, surgery, genetic testing, and precision medicine. Diagnostic capabilities encompass advanced pathology, molecular diagnostics, and imaging, supporting accurate and timely cancer detection and monitoring. The infrastructure is designed to facilitate continuous patient care, integrating consultations, exams, and therapies throughout the treatment process.

Oncoclínicas&Co operates with a multidisciplinary team that includes professionals in nursing, pharmacy, nutrition, psychology, and stomatology. This team approach ensures that patients receive comprehensive support, addressing both medical and complementary care needs such as physiotherapy, nutritional guidance, and psychological support. The organization’s clinical staff includes over 700 medical professionals, with specialists in oncology, hematology, radiotherapy, and genomics, as well as pediatric experts dedicated to child and adolescent oncology.

The clinic’s facilities are equipped to perform a variety of procedures, including surgeries, biopsies, and diagnostic imaging. Integrated cancer centers, genomics laboratories, and pathology units are part of the network, enabling the delivery of specialized and coordinated care. The Medicina de Precisão unit is equipped with advanced genomic sequencing platforms, such as Illumina MiSeq, NextSeq, and NovaSeq, which support molecular testing and drive oncology research and innovation within the organization.

Oncoclínicas&Co maintains an exclusive partnership in Brazil with the Dana-Farber Cancer Institute, affiliated with Harvard Medical School. This collaboration enhances the clinic’s research and treatment capabilities, providing access to international expertise and resources. The organization also supports clinical research, educational events, and publications, offering resources for both patients and medical professionals.

The medical responsible for the organization is Dr. Mariana Laloni (CRM-SP 102379). The clinic emphasizes high-quality medical education as part of its clinical team development, ensuring that staff remain current with advances in cancer care and research.

Through its integrated network, multidisciplinary teams, and advanced technological resources, Oncoclínicas&Co provides comprehensive oncology services, supporting patients from diagnosis through all stages of treatment. The organization’s commitment to precision medicine and ongoing research contributes to the development and application of innovative cancer therapies in Brazil.